FDA Inspection 1166309 — Lupin Limited
The FDA completed an inspection of Lupin Limited on Apr 4, 2022 in Tarapur, Thane. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tarapur, Thane (India)